Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 22 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Endoscopic ultrasonography differentiates lymph malignancies

Contrast-enhanced-endoscopic ultrasonography is useful for differentiating benign lymph nodes from malignant lymph nodes, reports the latest American Journal of Gastroenterology.

News image

fiogf49gjkf04

Endoscopic ultrasonography is considered the most useful diagnostic modality for regional staging

It is still difficult to diagnose lymph node metastasis by endoscopic ultrasonography images only.

Dr Yoshiki Hirooka and colleagues from Japan report the usefulness of contrast-enhanced endoscopic ultrasonography in the evaluation of benign or malignant lymph nodes based on blood flow patterns.

The researchers performed contrast-enhanced endoscopic ultrasonography in 46 patients with a lymph node in the mediastinum or abdominal cavity.

The subjects consisted of 22 patients with benign lymph nodes and 24 patients with malignant lymph nodes.

The research team conducted both a retrospective and prospective study.

The lesions were examined by endoscopic ultrasonography, and the maximal and minimal diameters of lymph nodes were measured.

Sensitivity rate of contrast-enhanced-endoscopic ultrasonography was 100%
American Journal of Gastroenterology

Thereafter, the shape and internal echoes were investigated, and the findings were morphologically classified based on Catalano's report.

Enhancement effects and the diagnostic capability of contrast-enhanced- endoscopic ultrasonography were evaluated.

Benign lymph nodes were differentiated from malignant lymph nodes using the enhancement patterns on contrast-enhanced-endoscopic ultrasonography.

The researchers observed that in the retrospective study, there were no significant differences in the maximal diameter of malignant and benign lymph nodes.

The team also noted no differences in the maximal/minimal diameter ratio between malignant and benign lymph nodes.

The morphology was classified into 4 types.

Based on the morphological classification, the sensitivity, specificity, and accuracy rate were 87%, 76%, and 81%, respectively.

Using contrast-enhanced-endoscopic ultrasonography, the team classified the enhancement pattern into 3 types.

The benign lymph node lesions showed uniform enhancement.

The researchers observed a defect of enhancement in all patients with malignant lymph nodes.

The researchers found that sensitivity, specificity, and accuracy rate of contrast-enhanced-endoscopic ultrasonography were 100%, 85%, and 91%, respectively.

In the prospective study, the sensitivity, specificity, and accuracy rate of contrast-enhanced-endoscopic ultrasonography was 100%, 82%, and 92%, respectively.

Dr Hirooka's team concludes, “Contrast-enhanced-endoscopic ultrasonography is useful for differentiating of benign lymph nodes from malignant lymph nodes.”

Am J Gastroenterol 2006: 101(1): 45-51
17 January 2006

Go to top of page Email this page Email this page to a colleague

 22 November 2017 
Surgical treatment delays influence survival in colon cancer
 22 November 2017 
Golimumab in Crohn's disease
 22 November 2017 
Challenges of US-trained gastroenterologists when abroad
 21 November 2017 
Prepregnancy obesity and maternal mortality
 21 November 2017 
Preoperative optimization in IBD patients
 21 November 2017 
Cholangiopathy in critically ill patients
 20 November 2017 
Socioeconomic characteristics in diverticular disease
 20 November 2017 
Barriers to hepatitis C treatment
 20 November 2017 
Endoscopic indices of disease activity for Crohn’s
 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 15 November 2017 
Medication nonadherence and health care costs
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Heartburn relief in adolescents with GERD
 01 November 2017 
Autoimmune pancreatitis in children
 31 October 2017 
Follow-up of positive results on fecal blood tests
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's
 26 October 2017 
Conversion to open laparotomy in rectal cancer
 25 October 2017 
Conversion of colonoscopy to sigmoidoscopy
 25 October 2017 
Rifaximin and survival in hepatic encephalopathy
 25 October 2017 
Fecal microbiota transplantation
 24 October 2017 
Eosinophilic esophagitis with swallowed topical corticosteroids
 24 October 2017 
Meta-analysis in nutritiona research

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us